...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Alteration of alpha1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats.
【24h】

Alteration of alpha1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats.

机译:12个月大的自发性高血压大鼠主动脉中α1-肾上腺素受体亚型的改变。

获取原文
获取原文并翻译 | 示例

摘要

Alterations in alpha1-adrenoceptor subtypes in aortas from 12-month-old spontaneously hypertensive rats (SHR) were studied in functional studies and RNase protection assays. The norepinephrine-induced contraction, including maximum response and pD2 values, was not significantly different between the SHR and age-matched Kyoto Wistar (WKY) rats. The pA2 values of the alpha1D-adrenoceptor subtype-selective antagonist BMY7378 (8-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro(4.5)dec ane-7,9-dionedihydrochloride) were increased from 8.10 +/- 0.12 in WKY rats to 8.45 +/- 0.13 in SHR (P < 0.05). The pA2 values of the alpha1A-adrenoceptor subtype-selective antagonist RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha,alpha-dim ethyl-1H-indole-3-ethanamine hydrochloride) were reduced from 8.52 +/- 0.20 in WKY rats to 7.82 +/- 0.18 in SHR (P < 0.05), whereas the pA2 values of the alpha1A/alpha1D-adrenoceptor subtype-selective antagonist WB4101 (2-(2,6-dimethoxphenoxyethyl)-aminomethyl-1,4 benzodioxane) were not significantly different between WKY rats and SHR (9.05 +/- 0.22 versus 9.27 +/- 0.15, P > 0.05). Preincubation of preparations in 50 microM chloroethylclonidine for 30 min irreversibly inhibited the norepinephrine-induced response more profoundly in aortas from SHR than in aortas from WKY rats. The results of RNase protection assays showed that mRNAs for alpha1A- and alpha1B-adrenoceptor subtypes were decreased and that mRNA for the alpha1D-adrenoceptor subtype was increased in aortas from SHR compared with WKY rats. The results suggested that the alpha1A-adrenoceptor subtype was decreased and the alpha1D-adrenoceptor subtype was increased in aortas of 12-month-old SHR.
机译:在功能研究和RNase保护试验中研究了12个月大自发性高血压大鼠(SHR)主动脉中α1-肾上腺素受体亚型的变化。在SHR和年龄匹配的Kyoto Wistar(WKY)大鼠之间,去甲肾上腺素诱导的收缩(包括最大反应和pD2值)没有显着差异。 α1D-肾上腺素受体亚型选择性拮抗剂BMY7378(8-(2-(4-(2-(2-甲氧基苯基)-1-哌嗪基)乙基)-8-氮杂螺(4.5)癸烷-7,9-二酮二盐酸盐的pA2值从WKY大鼠的8.10 +/- 0.12增加到SHR的8.45 +/- 0.13(P <0.05)。 α1A-肾上腺素受体亚型选择性拮抗剂RS-17053(N- [2-(2-环丙基甲氧基苯氧基)乙基] -5-氯-α,二甲基-1H-吲哚-3-乙胺盐酸盐)的pA2值为从WKY大鼠的8.52 +/- 0.20降低到SHR的7.82 +/- 0.18(P <0.05),而alpha1A / alpha1D-肾上腺素受体亚型选择性拮抗剂WB4101(2-(2,6-dimethoxphenoxyethyl)的pA2值-氨基甲基-1,4苯并二恶烷)在WKY大鼠和SHR之间无显着差异(9.05 +/- 0.22对9.27 +/- 0.15,P> 0.05)。在50 microM氯乙基可乐定中将制剂预孵育30分钟,与WKY大鼠的主动脉相比,不可逆地更明显地抑制了SHR主动脉中去甲肾上腺素诱导的反应。 RNase保护测定的结果表明,与WKY大鼠相比,SHR的主动脉中α1A和α1B肾上腺素受体亚型的mRNA均降低,而α1D肾上腺素受体亚型的mRNA升高。结果表明,在12个月大的SHR主动脉中,α1A-肾上腺素受体亚型减少而α1D-肾上腺素受体亚型增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号